Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
08/2004
08/19/2004CA2515297A1 Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis
08/18/2004EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors
08/18/2004EP1446487A1 Mammalian protein phosphatases
08/18/2004EP1446407A2 (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor
08/18/2004EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
08/18/2004EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS
08/18/2004EP1446382A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors
08/18/2004EP1446381A1 Anthranilic acid amides and pharmaceutical use thereof
08/18/2004EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists
08/18/2004EP1446144A2 The use of leptin in infertility
08/18/2004EP1446122A1 Use of flibanserin in the treatment of sexual disorders
08/18/2004EP1446116A1 Inhibitors of dipeptidyl peptidase iv
08/18/2004EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
08/18/2004EP1286997B1 6-phenylpyrrolopyrimidinedione derivatives
08/18/2004EP1178833B1 Topical compositions for prostaglandin e 1 delivery
08/18/2004EP1175397B1 3,3-substituted indoline derivatives
08/18/2004EP1117390B1 Mucosal originated drug delivery systems
08/18/2004EP0876166B1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body
08/18/2004EP0744950B1 Agent for prophylaxis and treatment of thromboxane a2 mediated diseases
08/18/2004EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof
08/18/2004CN1522257A Thiepino[3,2-b]dihydropyridines and related compositions and methods
08/18/2004CN1522155A Method for producing a vaccine
08/18/2004CN1522149A Promoting whole body health
08/18/2004CN1522145A Compositions and methods for treating vulvovaginitis and vaginosis
08/18/2004CN1522143A Coenzyme q and eicosapentaenoic acid (epa)
08/18/2004CN1520881A Sterilizing preparation for preventing and curing bovine mastitis and preparing process thereof
08/18/2004CN1520871A Effervescence granulas for treating gynecologic inflammations and preparing process thereof
08/18/2004CN1520855A Traditional Chinese medicine oral liquid for qi and blood nourishment, vein relaxing and milk secreting, and its production method
08/18/2004CN1520816A Sophocarpidine gel preparation and its process
08/18/2004CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof
08/18/2004CN1162176C Medicine for treating menopausal syndrome
08/18/2004CN1162171C Gynecopathy treating traditional Chinese medicine
08/18/2004CN1162165C Conception and childbearing helping band
08/18/2004CN1162153C Benzothiophenes series, formulations containing same, and methods
08/17/2004USRE38566 Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome
08/17/2004US6777437 Antidepressants, anxiolytic agents. sexual disorders
08/17/2004US6777427 Tetrahydroquinoline compounds
08/17/2004US6777419 Pyrazolo [4,3-d]pyrimidines
08/17/2004US6777416 Isoxazolo pyrimidinones and the use thereof
08/17/2004US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists
08/17/2004US6777386 Peptide agonist or analogue other than deslorelin; lecithin and stearin; preferably comprises a gnrh agonist and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial
08/17/2004US6776991 Treating painful penile erection; sexual disorders
08/17/2004US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc.
08/17/2004US6776164 Enhanced intravaginal devices
08/17/2004CA2292921C Aryl carboxylic acid and tetrazole derivatives
08/12/2004WO2004067741A1 Transcriptional activator
08/12/2004WO2004067535A1 Thienopyrimidine compounds and use thereof
08/12/2004WO2004045613A3 Use of domperidone for reducing fertility in mammalian females
08/12/2004WO2004037262A3 Immediate release topical pharmaceutical formulation for enhancement of female sexual desire and responsiveness
08/12/2004WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound
08/12/2004WO2003106444A8 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
08/12/2004WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy
08/12/2004US20040158076 Tyrosine derivatives
08/12/2004US20040157914 Pyrrolidinone derivatives
08/12/2004US20040157893 Pyrazole compounds useful as protein kinase inhibitors
08/12/2004US20040157857 Substituted chroman derivatives
08/12/2004US20040157830 Formailide derivatives as beta2-adrenoreceptor agonists
08/12/2004US20040157812 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
08/12/2004US20040157808 successfully treated by administering an aromatase inhibitor
08/12/2004US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
08/12/2004US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
08/12/2004US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor
08/12/2004US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein
08/12/2004US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain
08/12/2004US20040157259 Novel human ion channel protein and polynucleotides encoding the same
08/12/2004US20040157227 uses detection of relatively increased levels of ghrelin, an exon 3-deleted form of preproghrelin and/or growth hormone secretagogue type 1b receptor expression
08/12/2004US20040157073 Lubricious coatings for substrates
08/12/2004US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner
08/12/2004US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating
08/12/2004US20040156790 Delivery of drug esters through an inhalation route
08/12/2004US20040156789 Delivery of antihistamines through an inhalation route
08/12/2004US20040156788 Delivery of erectile dysfunction drugs through an inhalation route
08/12/2004US20040154549 Method for supplying bioavailable methionine to a cow
08/12/2004CA2508340A1 Transcriptional activator
08/11/2004EP1444234A2 Deuterated pyrazolopyrimidinones and drugs containing said compounds
08/11/2004EP1444229A1 Pyrazole derivatives as psychopharmaceuticals
08/11/2004EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases
08/11/2004EP1444225A2 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists.
08/11/2004EP1444215A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/11/2004EP1444206A1 Substituted benzo b azepin-2-one compounds
08/11/2004EP1443940A1 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
08/11/2004EP1443939A1 Compositions for treatment of postmenopausal female sexual dysfunction
08/11/2004EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
08/11/2004EP1299105B1 Compositions comprising folic acid and zinc for improving semen quality
08/11/2004EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
08/11/2004EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
08/11/2004CN1520414A Novel compound, its prepn. and application
08/11/2004CN1520404A Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor
08/11/2004CN1520303A Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
08/11/2004CN1520298A Pyrazolopyrimidines as therapeutic agents
08/11/2004CN1520289A Method of delaying ejaculation
08/11/2004CN1520283A Control of compactability through crystallization
08/11/2004CN1519017A Combination of Chinese traditional medicine for treating menorrhagia as well as pharmaceutics and preparation method
08/11/2004CN1519016A Prepared Chinese medicine for improving function of female ovary as well as preparation method and application in pharmacy
08/11/2004CN1519001A External lotion of Chinese traditional medicine for treating inflammation in female reproductive system
08/11/2004CN1161352C Quinazoline derivatives
08/11/2004CN1161341C Fused pydiopyridazine inhibitors of cGMP phosphodiesterase
08/11/2004CN1161102C Topical hormonal composition with systemic effect
08/10/2004US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation
08/10/2004US6774132 Spirooxindole derivatives that act as analgesics